The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis
- PMID: 34074005
- PMCID: PMC8197383
- DOI: 10.3390/ijerph18115613
The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people across the globe. Previous coronavirus outbreaks led to worsened symptoms amongst pregnant women, suggesting that pregnant women are at greater risk.
Objectives: Our aim is to investigate the differences in clinical presentation, management, and prognosis of COVID-19 infection in pregnant and non-pregnant women.
Methods: We ran a search on electronic databases and analysis of the relevant articles was done using Revie Manager 5.4.
Results: The review consists of nine studies comprising 591,058 women (28,797 pregnant and 562,261 non-pregnant), with most of the data derived from two large studies. The risk of experiencing fever (RR: 0.74; 95% CI: 0.64-0.85), headache (RR: 0.77; 95% CI: 0.74-0.79), myalgia (RR: 0.92; 95% CI: 0.89-0.95), diarrhea (RR: 0.40, 95% CI: 0.39-0.43), chest tightness (RR: 0.86; 95% CI: 0.77-0.95), and expectoration (RR: 0.45; 95% CI: 0.21-0.97) were greater amongst non-pregnant COVID-19-infected women. Pregnant women with COVID-19 were less likely to be obese (RR: 0.68; 95% CI: 0.63-0.73) or have a smoking history (RR: 0.32; 95% CI: 0.26-0.39). COVID-19-infected non-pregnant women had a higher frequency of comorbidity such as chronic cardiac disease (RR: 0.58; 95% CI: 0.44-0.77), renal disease (RR: 0.45; 95% CI: 0.29-0.71), and malignancy (RR: 0.82; 95% CI: 0.68-0.98), compared to COVID-19-infected pregnant women. The risk of ICU admission (RR: 2.26; 95% CI: 1.68-3.05) and requirement of invasive mechanical ventilation (RR: 2.68; 95% CI: 2.07-3.47) were significantly higher amongst pregnant women.
Conclusions: Although the frequency of risk factors and the risk of experiencing clinical symptoms of COVID-19 were higher among non-pregnant women, COVID-19-infected pregnant women had a higher requirement of ICU admission and invasive mechanical ventilation compared to non-pregnant COVID-19-infected women. More well-conducted studies from varying contexts are needed to draw conclusions. Prospero registration: CRD42020204638.
Keywords: COVID-19; SARS-CoV-2; child-bearing age women; coronavirus 2; non-pregnant adults; pregnant.
Conflict of interest statement
The authors report no conflict of interest.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2. Cochrane Database Syst Rev. 2021. PMID: 34473343 Free PMC article. Review.
-
Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-June 7, 2020.MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775. doi: 10.15585/mmwr.mm6925a1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32584795 Free PMC article.
-
Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27. doi: 10.1002/uog.22088. Ultrasound Obstet Gynecol. 2020. PMID: 32430957 Free PMC article.
-
The association between pregnancy and COVID-19: A systematic review and meta-analysis.Am J Emerg Med. 2022 Jun;56:188-195. doi: 10.1016/j.ajem.2022.03.060. Epub 2022 Apr 6. Am J Emerg Med. 2022. PMID: 35413655 Free PMC article. Review.
Cited by
-
A Review of Cardiovascular Complications among Pregnant Patients with COVID-19.Rev Cardiovasc Med. 2022 Nov 16;23(11):383. doi: 10.31083/j.rcm2311383. eCollection 2022 Nov. Rev Cardiovasc Med. 2022. PMID: 39076200 Free PMC article. Review.
-
Maternal COVID-19 vaccination status and association with neonatal congenital anomalies.Front Pediatr. 2024 Apr 19;12:1355502. doi: 10.3389/fped.2024.1355502. eCollection 2024. Front Pediatr. 2024. PMID: 38706924 Free PMC article.
-
Factors associated with hospitalizations and deaths of pregnant women from Paraná due to COVID-19: a cross-sectional study.Rev Bras Epidemiol. 2024 Feb 5;27:e240005. doi: 10.1590/1980-549720240005. eCollection 2024. Rev Bras Epidemiol. 2024. PMID: 38324869 Free PMC article.
-
Reduction in preterm birth among COVID-19-vaccinated pregnant individuals in the United States.Am J Obstet Gynecol MFM. 2023 Oct;5(10):101114. doi: 10.1016/j.ajogmf.2023.101114. Epub 2023 Aug 3. Am J Obstet Gynecol MFM. 2023. PMID: 37543141
-
Hospitalization in pregnancy due to human respiratory syncytial virus associated disease.IDCases. 2023 Jul 21;33:e01849. doi: 10.1016/j.idcr.2023.e01849. eCollection 2023. IDCases. 2023. PMID: 37534298 Free PMC article.
References
-
- WHO Media Briefing on COVID-19—11 March 2020. [(accessed on 23 October 2020)]; Available online: https://www.who.int/director-general/speeches/detail/who-director-genera....
-
- WHO WHO COVID-19 Dashboard. [(accessed on 23 October 2020)]; Available online: https://covid19.who.int/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous